(+)-6-Chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-dibenzo[b,e][1,4]diazepin-11-one, its isolation and its use as a medicament
Abstract
Abstract Translated from German Beschrieben wird das (+)-6-Chlor-5,l0-dihydro-5-[(l-methyl-4-piperidinyl)-acetyl]-llH-dibenzo[b,e][l,4]-diazepin-ll-on, seine Isolierung aus einem Enantiomerengemisch und seine Verwendung als Arzneimittel. The (+) - 6-chloro-5, 10-dihydro-5 - [(1-methyl-4-piperidinyl) -acetyl] -llH-dibenzo [b, e] [1, 4] -diazepine-II is described -on, its isolation from a mixture of enantiomers and its use as a medicament. Die Verbindung zeichnet sich durch eine starke Wirkung gegen Ulcera des Magen-Darm-Traktes aus. The compound is characterized by a strong action against ulcers of the gastrointestinal tract.
Inventors
- 👤 Günter Dr. Dipl.-Chem. Trummlitz
- 👤 Wolfhard Dr. Dipl.-Chem. Engel
- 👤 Wolfgang Dr. Dipl.-Chem. Eberlein
- 👤 Gerhard Dr. Dipl.-Chem. Mihm
- 👤 Antonio Prof. Dr. Giachetti
Bibliographic Details
Claims Analysis
Total Claims: 0References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.